Literature DB >> 2155518

Orthostatic hypotension, catecholamines, and alpha-adrenergic receptors in mitral valve prolapse.

I J Schatz1, S Ramanathan, R Villagomez, C MacLean.   

Abstract

The reported association of mitral valve prolapse with autonomic dysfunction and neuroendocrine abnormalities is derived from studies of patients selected because of symptoms or specifically referred for investigation. To determine whether such associations occur in nonreferred and unselected women with mitral valve prolapse, we measured blood pressure, heart rate, and norepinephrine response to standing in 13 volunteers with mitral valve prolapse and in 11 control subjects. Platelet alpha-adrenergic receptor quantity and affinity on standing also were determined in all persons. No significant differences were found between the groups in any of these measurements. Although small subsets of women with mitral valve prolapse may indeed have associated neuroendocrine epiphenomena and autonomic dysfunction, it is probably incorrect to generalize these findings to the vast spectrum of those with mitral valve prolapse.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2155518      PMCID: PMC1002251     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  16 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine.

Authors:  J D Peuler; G A Johnson
Journal:  Life Sci       Date:  1977-09-01       Impact factor: 5.037

3.  Identification of alpha-adrenergic receptors in human platelets by [3H]dihydroergocryptine binding.

Authors:  K D Newman; L T Williams; N H Bishopric; R J Lefkowitz
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

4.  Mitral valve prolapse in anxiety neurosis (panic disorder).

Authors:  A Venkatesh; D L Pauls; R Crowe; R Noyes; C Van Valkenburg; J B Martins; R E Kerber
Journal:  Am Heart J       Date:  1980-09       Impact factor: 4.749

5.  Metabolic studies in mitral valve prolapse syndrome. A neuroendocrine--cardiovascular process.

Authors:  H Boudoulas; J C Reynolds; E Mazzaferri; C F Wooley
Journal:  Circulation       Date:  1980-06       Impact factor: 29.690

6.  Urinary catecholamines and mitral valve prolapse in panic-anxiety patients.

Authors:  R M Nesse; O G Cameron; A J Buda; D S McCann; G C Curtis; M J Huber-Smith
Journal:  Psychiatry Res       Date:  1985-01       Impact factor: 3.222

7.  Abnormal cardiovascular regulation in the mitral valve prolapse syndrome.

Authors:  F A Gaffney; B C Bastian; L B Lane; W F Taylor; J Horton; J E Schutte; R M Graham; W Pettinger; C G Blomqvist
Journal:  Am J Cardiol       Date:  1983-08       Impact factor: 2.778

8.  Dysautonomia in mitral valve prolapse.

Authors:  H C Coghlan; P Phares; M Cowley; D Copley; T N James
Journal:  Am J Med       Date:  1979-08       Impact factor: 4.965

9.  Orthostatic hypotension: a commonly unrecognized cause of symptoms in mitral valve prolapse.

Authors:  A D Santos; P K Mathew; A Hilal; W A Wallace
Journal:  Am J Med       Date:  1981-11       Impact factor: 4.965

Review 10.  Increased plasma catecholamine levels in patients with symptomatic mitral valve prolapse.

Authors:  A Pasternac; J F Tubau; P E Puddu; R B Król; J de Champlain
Journal:  Am J Med       Date:  1982-12       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.